US20080021114A1 - Compositions and Methods for the Prevention and Treatment of Diseases in Plants - Google Patents
Compositions and Methods for the Prevention and Treatment of Diseases in Plants Download PDFInfo
- Publication number
- US20080021114A1 US20080021114A1 US11/535,737 US53573706A US2008021114A1 US 20080021114 A1 US20080021114 A1 US 20080021114A1 US 53573706 A US53573706 A US 53573706A US 2008021114 A1 US2008021114 A1 US 2008021114A1
- Authority
- US
- United States
- Prior art keywords
- composition
- wax
- compositions
- present
- emulsifier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 121
- 238000000034 method Methods 0.000 title claims abstract description 44
- 201000010099 disease Diseases 0.000 title claims abstract description 38
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 38
- 238000011282 treatment Methods 0.000 title description 11
- 230000002265 prevention Effects 0.000 title description 4
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 claims abstract description 62
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 48
- 241000207199 Citrus Species 0.000 claims abstract description 45
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 41
- 239000000284 extract Substances 0.000 claims abstract description 34
- 241000196324 Embryophyta Species 0.000 claims abstract description 31
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 20
- 241000589634 Xanthomonas Species 0.000 claims abstract description 18
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 51
- 239000001993 wax Substances 0.000 claims description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 claims description 15
- 239000008347 soybean phospholipid Substances 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 235000013871 bee wax Nutrition 0.000 claims description 12
- 239000012166 beeswax Substances 0.000 claims description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- 241000894007 species Species 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 abstract description 19
- 208000031888 Mycoses Diseases 0.000 abstract description 16
- 208000035143 Bacterial infection Diseases 0.000 abstract description 15
- 208000022362 bacterial infectious disease Diseases 0.000 abstract description 12
- 239000004615 ingredient Substances 0.000 abstract description 8
- 231100000252 nontoxic Toxicity 0.000 abstract description 5
- 230000003000 nontoxic effect Effects 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 description 18
- 239000012895 dilution Substances 0.000 description 16
- 238000010790 dilution Methods 0.000 description 16
- 230000009467 reduction Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 6
- 239000000575 pesticide Substances 0.000 description 6
- 239000000230 xanthan gum Substances 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- 239000003085 diluting agent Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000417 fungicide Substances 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000008029 eradication Effects 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 206010061217 Infestation Diseases 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 241000589636 Xanthomonas campestris Species 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 231100000481 chemical toxicant Toxicity 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000001974 tryptic soy broth Substances 0.000 description 2
- 239000006150 trypticase soy agar Substances 0.000 description 2
- 108010050327 trypticase-soy broth Proteins 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241001157813 Cercospora Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241001533598 Septoria Species 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 241001143875 Xanthomonas alfalfae subsp. citrumelonis Species 0.000 description 1
- 241000589655 Xanthomonas citri Species 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- ZDXLFJGIPWQALB-UHFFFAOYSA-M disodium;oxido(oxo)borane;chlorate Chemical compound [Na+].[Na+].[O-]B=O.[O-]Cl(=O)=O ZDXLFJGIPWQALB-UHFFFAOYSA-M 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000005089 fruit drop Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002420 orchard Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012794 pre-harvesting Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- -1 soy lecithin Chemical compound 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N27/00—Biocides, pest repellants or attractants, or plant growth regulators containing hydrocarbons
Definitions
- the present invention relates to compositions and methods for the treatment and prevention of bacterial and fungal disease in plants.
- the important diseases which can be treated and prevented by such compositions and methods is citrus canker.
- citrus canker alone causes severe economic consequences in the world's citrus growing regions.
- the bacteria which causes citrus canker, Xanthomonas campestris pv. citri has been found in southern Asia, Japan, the Middle East, Africa, South America and now North America. Historically, citrus canker outbreaks have occurred in North America in the early 1900s and again in 1986. Fortunately, through the use of aggressive eradication techniques, the disease was eliminated in both instances.
- Citrus canker can be reintroduced when people inadvertantly transport infected citrus fruits and seedlings into citrus growing areas in the U.S. and elsewhere.
- Florida In the U.S., Florida is by far the state most at risk from citrus canker given its combination of high humidity throughout the year, seasonal hurricanes and frequent thunderstorms accompanied by high wind gusts. (See The University of Florida Plant Pathology Department Report at vvvvw.biotech.ufl.edu/PlantContainment/canker.htm.)
- Costs in managing the threat of citrus canker include capital investment for spray equipment, the lost value of affected fruit, costs associated with inspection and eradication, and costs associated with the creation of natural windbreaks and other defensive tactics.
- Current spraying programs include relatively expensive copper based sprays. The University of Florida Extension Service has estimated that if citrus canker became endemic in Florida, the total cost for countering endemic citrus canker, including the use of copper based sprays, could be more than $300 per acre.
- the present invention provides non-toxic, environmentally friendly, effective and economical compositions and methods which prevent and treat bacterial and fungal disease in plants. More particularly, the present invention is effective in preventing and treating disease caused by the various species of the bacteria Xanthomonas , including diseases such as citrus canker.
- Compositions according to the present invention include d-limonene as the primary active ingredient alone or in combination with wax and/or wax extract, monohydric alcohol and other ingredients. Applicants have unexpectedly found that such compositions are capable of preventing and treating bacterial and fungal disease in plants, including citrus canker.
- compositions and methods according to the present invention are environmentally friendly since they do not include or involve the use of toxic chemicals or chemicals at toxic levels. Accordingly, there are minimal regulatory limitations for the use of such compositions.
- the present invention also provides methods of making and using such compositions.
- one object of the present invention is to provide compositions for preventing and treating bacterial and fungal disease in plants, especially diseases caused by Xanthomonas species such as citrus canker, comprising d-limonene alone or in combination with wax and/or wax extract, monohydric alcohol and/or other ingredients.
- Another object of the present invention is to provide methods of making compositions for preventing and treating bacterial and fungal disease in plants, especially diseases caused by Xanthomonas species such as citrus canker.
- a further object of the present invention is to provide methods of preventing and treating disease in plants, including diseases caused by Xanthomonas species such as citrus canker, which include applying compositions described herein to plants.
- the present invention provides non-toxic, naturally-derived, environmentally friendly compositions and methods for treating and preventing bacterial and fungal diseases, especially disease caused by species of the bacteria Xanthomonas such as citrus canker.
- compositions of the present invention may comprise d-limonene alone or in combination with wax and/or wax extract, monohydric alcohol and other ingredients.
- Applicants have unexpectedly found that such compositions are capable of treating and preventing bacterial and fungal disease in plants, especially disease caused by Xanthomonas such as citrus canker.
- such treatments do not create any perceivable concommitant negative consequences such as, for example, fruit production decreases, leaf drop or leaf wilt.
- percentage amounts of an ingredient are by total weight of the composition in which that ingredient is included prior to any dilution of the composition with water or other diluent and/or prior to any freeze-drying process.
- compositions of the present invention include d-limonene.
- D-limonene is the major component of the oil extracted from citrus rind and has been used extensively as an ingredient in cleaning products.
- D-limonene in compositions according to the present invention may comprise up to about 100% of the non-diluted product.
- d-limonene may comprise by weight from about 0.5% to about 20.0%, in other embodiments from about 5.0% to about 15.0%, and in other embodiments from about 9.0% to about 11.0%.
- the weight percentage of d-limonene preferably drops to less than about 50% of the composition, more preferably less than about 20%, and most preferably less than about 10%.
- D-limonene may be present in diluted compositions in amounts as low as 0.01% by weight. D-limonene is commercially available from many sources.
- compositions of the present invention also may include wax material, more preferably an extract of wax material.
- the preferred wax material is beeswax.
- the wax and/or wax extract Prior to any dilution, may comprise from about 0.005% to about 10.0%, preferably from about 0.01% to about 1.0%, and more preferably from about 0.05% to about 0.5% and even more preferably about 0.1% of the composition.
- compositions according to the present invention may include benzoic acid, salicylic acid and paraffin, and/or extracts of any of the above, alone or in various combinations, in amounts by weight totaling those given above for wax and/or wax extract alone.
- Extracts of wax may be obtained by heating a wax and water mixture and then filtering the solution to obtain the extracts. In certain embodiments about 99% of the solids are filtered out leaving a substantially solid-free wax extract.
- the wax and/or wax extract may be present in amounts reflecting the degree of dilution. For example, if compositions according to the present invention are diluted prior to use by the inclusion of 3 parts diluent to 1 part concentrated composition, the amount of wax or wax extract will be about 25% of its original concentration by weight.
- Wax such as beeswax
- benzoic acid such as beeswax
- salicylic acid such as benzoic acid
- paraffin are commercially available from many sources.
- Preservative compositions of the present invention also may include emulsifiers such as soy lecithin.
- emulsifiers such as soy lecithin.
- surface-active properties which provide, for example, the reduction in mixing time and the maintenance of stability of dispersions.
- Emulsifiers such as soy lecithin also provide a desirable homogenous appearance and prevent surface separation.
- emulsifiers used in the present invention may comprise from about 0.05 to about 15%, more preferably from about 0.5 to about 10%, and more preferably from about 1 to about 5%.
- Lecithins, particularly soy lecithins are preferred in certain embodiments of the present invention.
- ingredients may be used, for example, in amounts described above either alone or in combination with soy lecithin.
- canola oil and/or caprylic acid may be used as emulsifiers. After dilution, the concentration by weight of emusifiers will drop in proportion to the extent of dilution as discussed above.
- Emulsifiers such as soy lecithin are commercially available from many sources.
- Compositions according to the present invention also may include monohydric alcohols such as methanol, ethanol and butanol, alone or in various combinations.
- a preferred monohydric alcohol is ethanol.
- a preferred combination of monohydric alcohols includes ethanol and methanol.
- Monohydric alcohols according to the present invention may be either denatured or non-denatured. Prior to dilution, monohydric alcohol may comprise from about 0.5% to about 15.0%, more preferably about 2.0 to about 12.0%, and even more preferably from about 4.0 to about 9.0% of the composition. After dilution, the concentration by weight of monohydric alcohol will drop in proportion to the extent of dilution as discussed above. Monohydric alcohols are commercially available from many sources.
- compositions of the present invention also may include other excipients.
- Other excipients may include potassium hydroxide, xanthan gum, and hydrochloric acid. Potassium hydroxide and hydrochloric acid may be used to control and adjust pH levels. Xanthan gum may be used to control and adjust viscosity and also provide product stability.
- potassium hydroxide When included in compositions according to the present invention prior to dilution, potassium hydroxide may comprise from about 0.01% to about 5.0%, more preferably from about 0.05% to about 2.0%, and even more preferably from about 0.05% to about 0.5% of the composition.
- xanthan gum When included in compositions according to the present invention, xanthan gum may comprise from about 0.01% to about 2.0%, preferably from about 0.01% to about 1.0%, and more preferably from about 0.1% to about 0.5% of the composition. After dilution the concentration by weight of these excipients, if present, will drop in proportion to the extent of dilution as discussed above. All of the above-mentioned excipients are commercially available from many sources.
- the balance of undiluted, concentrated forms of compositions according to the present invention may comprise water.
- the water may be purified and, if so, preferably has a bacterial colony count of less than about 100 colonies per ml.
- the water may be made alkaline by the addition of potassium hydroxide and preferably has a pH above about 10.0.
- the preferred water hardness is less than 1 grain per gallon or less than 50 ppm.
- water may comprise by weight from about 35% to about 99% of compositions according to the present invention.
- extremely concentrated compositions comprising, for example, higher amounts of d-limonene and wax and/or wax extract are intended to be within the scope of the invention. As such, water may be present in amounts lower than 35%.
- the present invention also provides methods of making the compositions described herein. Such methods can be as simple as providing concentrated forms of d-limonene in a suitable container. Methods also include combining d-limonene and water.
- compositions according the present invention may be made by (1) adding monohydric alcohol to water and mixing; (2) heating the alcohol and water mixture; (3) adding d-limonene and mixing; (4) heating the monohydric alcohol, d-limonene and water combination; (5) adding wax and/or wax extract and mixing further; (6) heating the monohydric alcohol, d-limonene, wax and/or wax extract and water mixture; (7) optionally filtering the mixture; and (8) optionally cooling the filtrate.
- the method of making compositions includes the steps of (1) adding potassium hydroxide to water and mixing; (2) adding monohydric alcohol (e.g., ethanol) to the water and mixing; (3) heating the potassium hydroxide, alcohol, and water mixture to about 175° F. for five minutes or less; (4) adding d-limonene to the water and mixing, while maintaining the temperature at about 175° F. for about 15 minutes (4) adding beeswax and/or beeswax extract to the water and mixing, while maintaining the temperature at about 170° F. for about 15 minutes; (5) adding xanthan gum and mixing vigorously while allowing the mixture to cool; (6) filtering the cooled mixture.
- monohydric alcohol e.g., ethanol
- compositions according to the present invention may include the steps of (1) mixing water, wax and/or wax extract, and potassium hydroxide in a container; (2) adding to the container d-limonene and an emulsifier, such as soy lecithin, and mixing; and (3) adding to the container a monohydric alcohol and mixing.
- methods of making compositions according to the present invention may include the steps of (1) mixing water, beeswax extract, and potassium hydroxide in a container; (2) adding to the container d-limonene and soy lecithin and mixing; and (3) adding to the container ethanol and mixing.
- methods of making compositions according to the present invention may include the steps of (1) mixing in a container water, beeswax extract and potassium hydroxide, wherein water is present in amounts by weight from about 35% to about 99%, wherein the beeswax extract is present in amounts by weight from about 0.005% to about 10.0%, and wherein potassium hydroxide is present in amounts by weight from about 0.01% to about 5.0%; (2) adding to the container d-limonene and soy lecithin and mixing, wherein the d-limonene is present in amounts by weight from about 0.5% to about 20.0%, and wherein soy lecithin is present in amounts by weight from about 0.05 to about 15%; and (3) adding to the container ethanol and mixing, wherein ethanol is present in amounts by weight from 0.5% to about 15.0%.
- d-limonene may be added prior to adding monohydric alcohol or wax and/or wax extract could be added before either d-limonene or monohydric alcohol.
- water may be heated in any heating step (if the particular method of making the composition includes heating water or water and other components) to between about 110° to about 272° F., preferably to between about 130° to about 210° F., and more preferably to between about 165° to about 180° F.
- the liquid mixture may then be pumped through filters at a pressure sufficient to effectively collect the composition.
- the filtering pressure may be from about 5 to about 100 psi, preferably is from about 10 to about 40 psi, and more preferably is about 30 psi.
- the composition may be cooled before use. Preferably the composition may be cooled to at least about 95° F. Cooling may be facilitated by the use of a heat exchanger.
- compositions according to the present invention also may be formed into a crystalline powder form to facilitate packaging, storage and use. This may be achieved, for example, by reducing the water content to about 10% of the composition, adding xanthan gum and gum arabic in roughly equal amounts, drying the composition, and then grinding to break up larger particles. Drying may be achieved by, for example, a vacuum drier, a fluidized bed drier, a low temperature roller drier, a vacuum extrusion drier or by other drying means.
- the present invention also includes methods of using compositions which can prevent and treat bacterial and fungal diseases in plants, especially diseases caused by Xanthomonas species, such as citrus canker.
- An effective amount of the compositions of the present invention can be applied to plants such as citrus trees.
- an effective amount means an amount that is sufficient to prevent and reduce bacterial or fungal disease affecting plants such as citrus canker. Accordingly, an effective amount can vary depending on whether the primary purpose is prevention or treatment, and if the latter, the severity of the disease state.
- compositions according to the present invention may be effectively applied to citrus trees in a concentration ranging from about 1% to about 80%. Preferably, the concentration will be between 10% and 50% and more preferably between 20% and 40%. To achieve such concentrations, compositions according to the present invention may be diluted with an appropriate diluent such as water. Other suitable diluents may be used instead of water, although water should be the most economical diluent. Alternatively, compositions according to the present invention may be incorporated into existing (or yet to be developed) formulations of herbicides, pesticides and fungicides, including those currently used by commercial growers. One benefit of including compositions according to the present invention into certain herbicides, pesticides and/or fungicides is that it may reduce the total amount of toxic chemicals that would otherwise be applied to plants, including citrus trees.
- compositions according to the present invention can be sprayed onto plants that do not have any observable disease using conventional spray equipment. Likewise, these compositions can be sprayed onto diseased plants in the same manner. For use in diseased plants, the concentration of compositions according to the present invention generally will be higher than for preventative treatments.
- compositions according to the present invention may reduce or eliminate the growth of a wide-range of disease-causing organisms in plants, including citrus trees. These compositions have been shown to be especially effective in the treatment and prevention of citrus canker caused by Xanthomonas , including Xanthomonas campestris pv. Citri , the causative agent of citrus canker.
- compositions according to the present invention are also effective in treating and preventing bacterial and fungal infections (and/or infestations) in other types of plants.
- diseases include (but are not limited to) diseases caused by other Xanthomonas species, diseases caused by Pseudomonas , and diseases caused by other bacteria, as well as fungal diseases and disease caused by infestation of certain insects.
- compositions and methods according to the present invention are also effective in preventing and/or treating diseases in tomatoes, bell peppers, grapes and other plants.
- such compositions will be effective in treating and preventing diseases of tomatoes including bacterial spot, caused by Xanthomonas campestris pv. Vesicatoria .
- Compositions according to the present invention also will be effective in treating and preventing early blight, late blight and septoria leaf spot.
- compositions will be effective in treating and preventing disease in bell peppers (and other peppers) such as, for example, bacterial leaf spot, cercospora leaf spot, southern blight and tobacco mosaic virus.
- compositions according to the present invention also will be effective in treating and/or preventing diseases associated with the wine industry. Such diseases include those effecting grapes or vines caused by fungi, such as mildew and various rot conditions, diseases caused by bacteria, such as bacterial blight and Pierce's disease, grapevine yellows disease, and diseases caused by viruses. Compositions according to the present invention also will reduce the incidence of Pylloxera.
- composition as shown in Table 1 was used to demonstrate the effectiveness of an exemplary embodiment of the present invention in treating citrus canker: TABLE 1 monohydric alcohol (ethanol) 6.65% d-limonene 10.00% beeswax extract 1.47% water 81.40 potassium hydroxide 0.16% xanthan gum 0.16%
- compositions in accordance with Table 1 above were tested on cultures of Xanthomonas campestris pv. citrumelo obtained from the Florida Department of Plant Industry, Florida Department of Agriculture & Consumer Services, Gainesville, Fla.
- Xanthomonas was grown via at least two transfers at 30° C. for 48 hr in Tryptic Soy broth (TSB). The final culture was centrifuged at 10,000 ⁇ g for 10 min., the cells resuspended in sterile Butterfield's phosphate buffer (BPB) to obtain 10 mL of a suspension with an approximate cell density of 1 ⁇ 10 8 CFU/mL. The final working inoculum suspension was enumerated.
- TLB Tryptic Soy broth
- Sample aliquots from the initial (10 ⁇ 1 ) neutralizing tubes were serially diluted in BPB and enumerated via surface plating on pre-poured plates of Tryptic Soy agar (CYSA) agar, TSA plates were incubated for 48 h at 30° C.
- CYSA Tryptic Soy agar
- Bacterial counts were expressed as colony forming units per ml of sample solution and converted to log 10 transforms. Log 10 mean counts were calculated for each solution time variable. The log 10 reduction and percentage reduction (versus the control sample after 30 sec.) was also calculated for each exposure time.
- compositions according to the present invention were shown to be highly effective in reducing Xanthomonas counts.
- the control (BPB buffer) count of Xanthomonas was 6.11, 6.04, 6.11, and 5.94 log 10 CFU/ml of solution after 30 sec., 1 min. 5 min., and 10 min., respectively.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
- This application is a continuation-in-part of U.S. application Ser. No. 11/093,501 filed on Mar. 30, 2005, the entire contents of which are incorporated herein by reference.
- The present invention relates to compositions and methods for the treatment and prevention of bacterial and fungal disease in plants. Among the important diseases which can be treated and prevented by such compositions and methods is citrus canker.
- As reported by the University of Florida Plant Pathology Department, fungal and bacterial pathogens can lower yields, reduce quality, negatively affect the aesthetic and economic value and even ultimately destroy plants, crops, pre-harvest fruits, trees, vegetables and grasses. In particular, bacterial and fungal diseases in citrus plants create huge economic burdens on the citrus industry worldwide. Citrus canker alone causes severe economic consequences in the world's citrus growing regions. The bacteria which causes citrus canker, Xanthomonas campestris pv. citri, has been found in southern Asia, Japan, the Middle East, Africa, South America and now North America. Historically, citrus canker outbreaks have occurred in North America in the early 1900s and again in 1986. Fortunately, through the use of aggressive eradication techniques, the disease was eliminated in both instances. Citrus canker, however, can be reintroduced when people inadvertantly transport infected citrus fruits and seedlings into citrus growing areas in the U.S. and elsewhere. In the U.S., Florida is by far the state most at risk from citrus canker given its combination of high humidity throughout the year, seasonal hurricanes and frequent thunderstorms accompanied by high wind gusts. (See The University of Florida Plant Pathology Department Report at vvvvw.biotech.ufl.edu/PlantContainment/canker.htm.)
- The University of Florida Extension Service reports that in 1995 citrus canker was again detected in the U.S. in citrus trees in the Miami-Dade County, Fla. area. Citrus canker then spread to the commercial groves in southwest Florida. Since 1998 more than 870,000 trees have been destroyed in conjunction with eradication programs. (See http://edis.ifas.ufl.edu/FE286)
- Costs in managing the threat of citrus canker include capital investment for spray equipment, the lost value of affected fruit, costs associated with inspection and eradication, and costs associated with the creation of natural windbreaks and other defensive tactics. Current spraying programs include relatively expensive copper based sprays. The University of Florida Extension Service has estimated that if citrus canker became endemic in Florida, the total cost for countering endemic citrus canker, including the use of copper based sprays, could be more than $300 per acre.
- Many types of organic molecules possess antimicrobial properties and can he used to effectively control fungal and bacterial disease in plants. For example, previous attempts to control such disease in plants includes, for example, copper-containing fungicide and streptomycin sprays. Other fungicides, herbicides and pesticides have been used as well.
- However, many of the currently used products are toxic to humans, animals and the exposed environment which limits large scale application of such products in, for example, citrus orchards, The Environmental Protection Act was established in 1972, in part, to address concerns over the use of potentially toxic materials to control or treat diseases in crops. In 1996 Congress passed the Food Quality Protection Act requiring the Environmental Protection Agency to reassess the safety and efficacy of every existing pesticide by 2006. Concerns about pesticide residues on plants and the exposure of field workers to such residues severely limits the amounts of pesticide that can be applied and the timing of such application. These limitations decrease the potential effectiveness of commonly used pesticides to prevent and treat bacterial and fungal disease in plants in general and citrus canker in particular.
- Accordingly, there exists a tremendous need for effective, economical and non-toxic compositions and methods for preventing and treating bacterial and fungal disease in plants. In particular there is a tremendous need for non-toxic, environmentally friendly, effective and economical compositions and methods for preventing and treating citrus canker.
- The present invention provides non-toxic, environmentally friendly, effective and economical compositions and methods which prevent and treat bacterial and fungal disease in plants. More particularly, the present invention is effective in preventing and treating disease caused by the various species of the bacteria Xanthomonas, including diseases such as citrus canker. Compositions according to the present invention include d-limonene as the primary active ingredient alone or in combination with wax and/or wax extract, monohydric alcohol and other ingredients. Applicants have unexpectedly found that such compositions are capable of preventing and treating bacterial and fungal disease in plants, including citrus canker.
- Moreover, compositions and methods according to the present invention are environmentally friendly since they do not include or involve the use of toxic chemicals or chemicals at toxic levels. Accordingly, there are minimal regulatory limitations for the use of such compositions.
- The present invention also provides methods of making and using such compositions.
- Accordingly, one object of the present invention is to provide compositions for preventing and treating bacterial and fungal disease in plants, especially diseases caused by Xanthomonas species such as citrus canker, comprising d-limonene alone or in combination with wax and/or wax extract, monohydric alcohol and/or other ingredients.
- Another object of the present invention is to provide methods of making compositions for preventing and treating bacterial and fungal disease in plants, especially diseases caused by Xanthomonas species such as citrus canker.
- A further object of the present invention is to provide methods of preventing and treating disease in plants, including diseases caused by Xanthomonas species such as citrus canker, which include applying compositions described herein to plants.
- The present invention provides non-toxic, naturally-derived, environmentally friendly compositions and methods for treating and preventing bacterial and fungal diseases, especially disease caused by species of the bacteria Xanthomonas such as citrus canker.
- The compositions of the present invention may comprise d-limonene alone or in combination with wax and/or wax extract, monohydric alcohol and other ingredients. Applicants have unexpectedly found that such compositions are capable of treating and preventing bacterial and fungal disease in plants, especially disease caused by Xanthomonas such as citrus canker. Moreover, such treatments do not create any perceivable concommitant negative consequences such as, for example, fruit production decreases, leaf drop or leaf wilt.
- As used herein, unless otherwise stated, percentage amounts of an ingredient are by total weight of the composition in which that ingredient is included prior to any dilution of the composition with water or other diluent and/or prior to any freeze-drying process.
- Compositions of the present invention include d-limonene. D-limonene is the major component of the oil extracted from citrus rind and has been used extensively as an ingredient in cleaning products. D-limonene in compositions according to the present invention may comprise up to about 100% of the non-diluted product. In certain embodiments prior to dilution, d-limonene may comprise by weight from about 0.5% to about 20.0%, in other embodiments from about 5.0% to about 15.0%, and in other embodiments from about 9.0% to about 11.0%.
- After dilution the weight percentage of d-limonene preferably drops to less than about 50% of the composition, more preferably less than about 20%, and most preferably less than about 10%. D-limonene may be present in diluted compositions in amounts as low as 0.01% by weight. D-limonene is commercially available from many sources.
- Compositions of the present invention also may include wax material, more preferably an extract of wax material. The preferred wax material is beeswax. Prior to any dilution, the wax and/or wax extract may comprise from about 0.005% to about 10.0%, preferably from about 0.01% to about 1.0%, and more preferably from about 0.05% to about 0.5% and even more preferably about 0.1% of the composition. Optionally, as a substitute for, or in addition to wax and/or wax extract, compositions according to the present invention may include benzoic acid, salicylic acid and paraffin, and/or extracts of any of the above, alone or in various combinations, in amounts by weight totaling those given above for wax and/or wax extract alone.
- Extracts of wax may be obtained by heating a wax and water mixture and then filtering the solution to obtain the extracts. In certain embodiments about 99% of the solids are filtered out leaving a substantially solid-free wax extract.
- After dilution, the wax and/or wax extract may be present in amounts reflecting the degree of dilution. For example, if compositions according to the present invention are diluted prior to use by the inclusion of 3 parts diluent to 1 part concentrated composition, the amount of wax or wax extract will be about 25% of its original concentration by weight.
- Wax (such as beeswax), benzoic acid, salicylic acid and paraffin are commercially available from many sources.
- Preservative compositions of the present invention also may include emulsifiers such as soy lecithin. Among the advantages of emulsifiers such as soy lecithin are surface-active properties which provide, for example, the reduction in mixing time and the maintenance of stability of dispersions. Emulsifiers such as soy lecithin also provide a desirable homogenous appearance and prevent surface separation. Prior to dilution, emulsifiers used in the present invention may comprise from about 0.05 to about 15%, more preferably from about 0.5 to about 10%, and more preferably from about 1 to about 5%. Lecithins, particularly soy lecithins are preferred in certain embodiments of the present invention. Other ingredients may be used, for example, in amounts described above either alone or in combination with soy lecithin. For example, canola oil and/or caprylic acid may be used as emulsifiers. After dilution, the concentration by weight of emusifiers will drop in proportion to the extent of dilution as discussed above. Emulsifiers such as soy lecithin are commercially available from many sources.
- Compositions according to the present invention also may include monohydric alcohols such as methanol, ethanol and butanol, alone or in various combinations. A preferred monohydric alcohol is ethanol. A preferred combination of monohydric alcohols includes ethanol and methanol. Monohydric alcohols according to the present invention may be either denatured or non-denatured. Prior to dilution, monohydric alcohol may comprise from about 0.5% to about 15.0%, more preferably about 2.0 to about 12.0%, and even more preferably from about 4.0 to about 9.0% of the composition. After dilution, the concentration by weight of monohydric alcohol will drop in proportion to the extent of dilution as discussed above. Monohydric alcohols are commercially available from many sources.
- Compositions of the present invention also may include other excipients. Other excipients may include potassium hydroxide, xanthan gum, and hydrochloric acid. Potassium hydroxide and hydrochloric acid may be used to control and adjust pH levels. Xanthan gum may be used to control and adjust viscosity and also provide product stability. When included in compositions according to the present invention prior to dilution, potassium hydroxide may comprise from about 0.01% to about 5.0%, more preferably from about 0.05% to about 2.0%, and even more preferably from about 0.05% to about 0.5% of the composition. When included in compositions according to the present invention, xanthan gum may comprise from about 0.01% to about 2.0%, preferably from about 0.01% to about 1.0%, and more preferably from about 0.1% to about 0.5% of the composition. After dilution the concentration by weight of these excipients, if present, will drop in proportion to the extent of dilution as discussed above. All of the above-mentioned excipients are commercially available from many sources.
- The balance of undiluted, concentrated forms of compositions according to the present invention may comprise water. The water may be purified and, if so, preferably has a bacterial colony count of less than about 100 colonies per ml. The water may be made alkaline by the addition of potassium hydroxide and preferably has a pH above about 10.0. The preferred water hardness is less than 1 grain per gallon or less than 50 ppm. In certain embodiments water may comprise by weight from about 35% to about 99% of compositions according to the present invention. As discussed previously, extremely concentrated compositions comprising, for example, higher amounts of d-limonene and wax and/or wax extract are intended to be within the scope of the invention. As such, water may be present in amounts lower than 35%.
- Methods of Making
- The present invention also provides methods of making the compositions described herein. Such methods can be as simple as providing concentrated forms of d-limonene in a suitable container. Methods also include combining d-limonene and water.
- In another embodiment, compositions according the present invention may be made by (1) adding monohydric alcohol to water and mixing; (2) heating the alcohol and water mixture; (3) adding d-limonene and mixing; (4) heating the monohydric alcohol, d-limonene and water combination; (5) adding wax and/or wax extract and mixing further; (6) heating the monohydric alcohol, d-limonene, wax and/or wax extract and water mixture; (7) optionally filtering the mixture; and (8) optionally cooling the filtrate.
- In another embodiment the method of making compositions includes the steps of (1) adding potassium hydroxide to water and mixing; (2) adding monohydric alcohol (e.g., ethanol) to the water and mixing; (3) heating the potassium hydroxide, alcohol, and water mixture to about 175° F. for five minutes or less; (4) adding d-limonene to the water and mixing, while maintaining the temperature at about 175° F. for about 15 minutes (4) adding beeswax and/or beeswax extract to the water and mixing, while maintaining the temperature at about 170° F. for about 15 minutes; (5) adding xanthan gum and mixing vigorously while allowing the mixture to cool; (6) filtering the cooled mixture.
- In another embodiment methods of making compositions according to the present invention may include the steps of (1) mixing water, wax and/or wax extract, and potassium hydroxide in a container; (2) adding to the container d-limonene and an emulsifier, such as soy lecithin, and mixing; and (3) adding to the container a monohydric alcohol and mixing.
- In another embodiment, methods of making compositions according to the present invention may include the steps of (1) mixing water, beeswax extract, and potassium hydroxide in a container; (2) adding to the container d-limonene and soy lecithin and mixing; and (3) adding to the container ethanol and mixing.
- In yet another embodiment, methods of making compositions according to the present invention may include the steps of (1) mixing in a container water, beeswax extract and potassium hydroxide, wherein water is present in amounts by weight from about 35% to about 99%, wherein the beeswax extract is present in amounts by weight from about 0.005% to about 10.0%, and wherein potassium hydroxide is present in amounts by weight from about 0.01% to about 5.0%; (2) adding to the container d-limonene and soy lecithin and mixing, wherein the d-limonene is present in amounts by weight from about 0.5% to about 20.0%, and wherein soy lecithin is present in amounts by weight from about 0.05 to about 15%; and (3) adding to the container ethanol and mixing, wherein ethanol is present in amounts by weight from 0.5% to about 15.0%.
- It should be noted that the order of steps recited above in embodiments of the present invention may be varied to produce compositions according to the present invention. For example, d-limonene may be added prior to adding monohydric alcohol or wax and/or wax extract could be added before either d-limonene or monohydric alcohol.
- In certain examples of embodiments of the present invention, water may be heated in any heating step (if the particular method of making the composition includes heating water or water and other components) to between about 110° to about 272° F., preferably to between about 130° to about 210° F., and more preferably to between about 165° to about 180° F.
- The liquid mixture may then be pumped through filters at a pressure sufficient to effectively collect the composition. The filtering pressure may be from about 5 to about 100 psi, preferably is from about 10 to about 40 psi, and more preferably is about 30 psi. The composition may be cooled before use. Preferably the composition may be cooled to at least about 95° F. Cooling may be facilitated by the use of a heat exchanger.
- Compositions according to the present invention also may be formed into a crystalline powder form to facilitate packaging, storage and use. This may be achieved, for example, by reducing the water content to about 10% of the composition, adding xanthan gum and gum arabic in roughly equal amounts, drying the composition, and then grinding to break up larger particles. Drying may be achieved by, for example, a vacuum drier, a fluidized bed drier, a low temperature roller drier, a vacuum extrusion drier or by other drying means.
- Methods of Using
- The present invention also includes methods of using compositions which can prevent and treat bacterial and fungal diseases in plants, especially diseases caused by Xanthomonas species, such as citrus canker. An effective amount of the compositions of the present invention can be applied to plants such as citrus trees. In this context an effective amount means an amount that is sufficient to prevent and reduce bacterial or fungal disease affecting plants such as citrus canker. Accordingly, an effective amount can vary depending on whether the primary purpose is prevention or treatment, and if the latter, the severity of the disease state.
- In general, however, compositions according to the present invention may be effectively applied to citrus trees in a concentration ranging from about 1% to about 80%. Preferably, the concentration will be between 10% and 50% and more preferably between 20% and 40%. To achieve such concentrations, compositions according to the present invention may be diluted with an appropriate diluent such as water. Other suitable diluents may be used instead of water, although water should be the most economical diluent. Alternatively, compositions according to the present invention may be incorporated into existing (or yet to be developed) formulations of herbicides, pesticides and fungicides, including those currently used by commercial growers. One benefit of including compositions according to the present invention into certain herbicides, pesticides and/or fungicides is that it may reduce the total amount of toxic chemicals that would otherwise be applied to plants, including citrus trees.
- Compositions according to the present invention can be sprayed onto plants that do not have any observable disease using conventional spray equipment. Likewise, these compositions can be sprayed onto diseased plants in the same manner. For use in diseased plants, the concentration of compositions according to the present invention generally will be higher than for preventative treatments.
- Compositions according to the present invention may reduce or eliminate the growth of a wide-range of disease-causing organisms in plants, including citrus trees. These compositions have been shown to be especially effective in the treatment and prevention of citrus canker caused by Xanthomonas, including Xanthomonas campestris pv. Citri, the causative agent of citrus canker.
- In addition to use in citrus species, compositions according to the present invention are also effective in treating and preventing bacterial and fungal infections (and/or infestations) in other types of plants. Such diseases include (but are not limited to) diseases caused by other Xanthomonas species, diseases caused by Pseudomonas, and diseases caused by other bacteria, as well as fungal diseases and disease caused by infestation of certain insects.
- In addition to citrus plants, compositions and methods according to the present invention are also effective in preventing and/or treating diseases in tomatoes, bell peppers, grapes and other plants. For example, such compositions will be effective in treating and preventing diseases of tomatoes including bacterial spot, caused by Xanthomonas campestris pv. Vesicatoria. Compositions according to the present invention also will be effective in treating and preventing early blight, late blight and septoria leaf spot.
- Similarly, such compositions will be effective in treating and preventing disease in bell peppers (and other peppers) such as, for example, bacterial leaf spot, cercospora leaf spot, southern blight and tobacco mosaic virus.
- Compositions according to the present invention also will be effective in treating and/or preventing diseases associated with the wine industry. Such diseases include those effecting grapes or vines caused by fungi, such as mildew and various rot conditions, diseases caused by bacteria, such as bacterial blight and Pierce's disease, grapevine yellows disease, and diseases caused by viruses. Compositions according to the present invention also will reduce the incidence of Pylloxera.
- The composition as shown in Table 1 was used to demonstrate the effectiveness of an exemplary embodiment of the present invention in treating citrus canker:
TABLE 1 monohydric alcohol (ethanol) 6.65% d-limonene 10.00% beeswax extract 1.47% water 81.40 potassium hydroxide 0.16% xanthan gum 0.16% - Ten citrus trees with existing canker lesions were drench sprayed with a 25% solution of the composition according to Table 1, while ten citrus trees were used as controls. Tree limbs were tagged with strips of caution tape to facilitate precise identification of the treatment trees. Weekly observations were taken to determine the effect of the treatment on the canker lesions. A second treatment was applied approximately two weeks after the first. Over the course of eight weeks of observation, canker lesions had not expanded on the ten treatment trees, while canker lesions had grown substantially on the ten control trees. The treatment trees and control trees both exhibited similar insubstantial levels of leaf wilting and fruit drop.
- In order to more precisely quantify the effectiveness of compositions according to the present invention, compositions in accordance with Table 1 above were tested on cultures of Xanthomonas campestris pv. citrumelo obtained from the Florida Department of Plant Industry, Florida Department of Agriculture & Consumer Services, Gainesville, Fla.
- Test Procedures
- Xanthomonas was grown via at least two transfers at 30° C. for 48 hr in Tryptic Soy broth (TSB). The final culture was centrifuged at 10,000×g for 10 min., the cells resuspended in sterile Butterfield's phosphate buffer (BPB) to obtain 10 mL of a suspension with an approximate cell density of 1×108 CFU/mL. The final working inoculum suspension was enumerated.
- A modification of the AOAC Method 960.09 (Germicidal and Detergent Sanitizing Action of Disinfectants) was used to test the disinfectant efficacy of a solution of the composition.
-
- 1) Two flasks containing 99 ml each of the antimicrobial solution were prepared in sterile 250 ml flasks containing sterile stir bars. A single flask of control solution (99 ml of sterile Butterfield's phosphate buffer (BPB) was also prepared. The flasks were equilibrated to room temperature (22-25° C.) before initiating the efficacy tests.
- 2) One ml of the inoculum suspension (108 CFU/ml) was inoculated into each of the flasks while stirring slowly to yield a flask inoculum level of ca. 106 CFU/ml. The flasks were stirred slowly during the tests.
- 3) Each flask was sampled 30 sec. after inoculation and subsequently after 1, 5, and 10 min. of incubation/exposure at 25° C. Flasks were sampled by aseptically transferring a one ml aliquot to a tube containing 9.0 ml of Difco neutralizing broth (to yield an initial dilution of 1:10).
Microbial Analysis
- Sample aliquots from the initial (10−1) neutralizing tubes were serially diluted in BPB and enumerated via surface plating on pre-poured plates of Tryptic Soy agar (CYSA) agar, TSA plates were incubated for 48 h at 30° C.
- Bacterial counts were expressed as colony forming units per ml of sample solution and converted to log10 transforms. Log10 mean counts were calculated for each solution time variable. The log10 reduction and percentage reduction (versus the control sample after 30 sec.) was also calculated for each exposure time.
- Results
- Compositions according to the present invention were shown to be highly effective in reducing Xanthomonas counts. The control (BPB buffer) count of Xanthomonas was 6.11, 6.04, 6.11, and 5.94 log10 CFU/ml of solution after 30 sec., 1 min. 5 min., and 10 min., respectively. There was an increasing reduction of Xanthomonas counts in the test solution as the exposure times increased with significant reductions (i.e., >1 log10 CFU/ml) noted after 5 and 10 min. exposure times. There was a 1.98 log10 CFU/ml (98.94%) reduction of mean Xanthomonas counts in the test solution following a 5 min. exposure time and a 4.16 log10 CFU/ml (99.995%) reduction of mean Xanthomonas counts following a 10 min. exposure time.
Claims (38)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/535,737 US20080021114A1 (en) | 2005-03-30 | 2006-09-27 | Compositions and Methods for the Prevention and Treatment of Diseases in Plants |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/093,501 US7226610B2 (en) | 2005-03-30 | 2005-03-30 | Compositions and methods for the treatment and prevention of disease in plants |
US11/535,737 US20080021114A1 (en) | 2005-03-30 | 2006-09-27 | Compositions and Methods for the Prevention and Treatment of Diseases in Plants |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/093,501 Continuation-In-Part US7226610B2 (en) | 2005-03-30 | 2005-03-30 | Compositions and methods for the treatment and prevention of disease in plants |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080021114A1 true US20080021114A1 (en) | 2008-01-24 |
Family
ID=37053718
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/093,501 Expired - Fee Related US7226610B2 (en) | 2005-03-30 | 2005-03-30 | Compositions and methods for the treatment and prevention of disease in plants |
US11/535,737 Abandoned US20080021114A1 (en) | 2005-03-30 | 2006-09-27 | Compositions and Methods for the Prevention and Treatment of Diseases in Plants |
US11/742,839 Abandoned US20070196409A1 (en) | 2005-03-30 | 2007-05-01 | Compositions and methods for the treatment and prevention of disease in plants |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/093,501 Expired - Fee Related US7226610B2 (en) | 2005-03-30 | 2005-03-30 | Compositions and methods for the treatment and prevention of disease in plants |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/742,839 Abandoned US20070196409A1 (en) | 2005-03-30 | 2007-05-01 | Compositions and methods for the treatment and prevention of disease in plants |
Country Status (2)
Country | Link |
---|---|
US (3) | US7226610B2 (en) |
WO (1) | WO2006105342A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100092631A1 (en) * | 2007-02-16 | 2010-04-15 | Alberto Sardo | Combinations of abietic acid esters with one or mote terpenes and use thereof for coating fruit or vegetables |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7226610B2 (en) * | 2005-03-30 | 2007-06-05 | Preservation Sciences, Inc. | Compositions and methods for the treatment and prevention of disease in plants |
US8221791B1 (en) | 2008-12-10 | 2012-07-17 | University Of Central Florida Research Foundation, Inc. | Silica-based antibacterial and antifungal nanoformulation |
BR112012025037B1 (en) | 2010-03-30 | 2018-06-05 | University Of Central Florida Research Foundation, Inc. | MULTI-FUNCTIONAL SILICA-GEL COMPOSITIONS, METHODS, AND METHODS OF USING THE SAME. |
US9491946B2 (en) | 2011-11-01 | 2016-11-15 | University Of Central Florida Research Foundation, Inc. | Ag loaded silica nanoparticle/nanogel formulation, methods of making, and methods of use |
US9781936B2 (en) | 2013-10-09 | 2017-10-10 | University Of Central Florida Research Foundation, Inc. | Compositions, methods of making a composition, and methods of use |
US9215877B2 (en) | 2014-02-05 | 2015-12-22 | University Of Central Florida Research Foundation, Inc. | Compositions including a vacancy-engineered(VE)-ZnO nanocomposite, methods of making a composition , method of using a composition |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5462690A (en) * | 1994-09-09 | 1995-10-31 | Colgate-Palmolive Co. | Liquid cleaning compositions |
US5843215A (en) * | 1997-04-07 | 1998-12-01 | Warmm Sciences, Llc | Insect repellent coatings |
US5935272A (en) * | 1999-02-02 | 1999-08-10 | Milliken & Company | Compositions comprising aryloxypolyoxyalkylene naphthalimide derivative colorants |
US6482455B1 (en) * | 1999-11-11 | 2002-11-19 | Inabonos S.A. | Natural source composition for the control of post-harvest pathologies and methods of application |
US20040161517A1 (en) * | 2003-02-14 | 2004-08-19 | Paul Winniczuk | Food and beverage preservative |
US7226610B2 (en) * | 2005-03-30 | 2007-06-05 | Preservation Sciences, Inc. | Compositions and methods for the treatment and prevention of disease in plants |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2938028A (en) * | 1956-10-15 | 1960-05-24 | Ventura Processors | Purifying and dewaxing citrus oils |
US6524605B1 (en) * | 1999-08-06 | 2003-02-25 | Iowa State University Research Foundation, Inc. | Biorational repellents obtained from terpenoids for use against arthropods |
WO2003020024A2 (en) * | 2001-08-28 | 2003-03-13 | Eden Research Plc | Treatment and prevention of infections in plants |
-
2005
- 2005-03-30 US US11/093,501 patent/US7226610B2/en not_active Expired - Fee Related
-
2006
- 2006-03-30 WO PCT/US2006/011759 patent/WO2006105342A1/en active Application Filing
- 2006-09-27 US US11/535,737 patent/US20080021114A1/en not_active Abandoned
-
2007
- 2007-05-01 US US11/742,839 patent/US20070196409A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5462690A (en) * | 1994-09-09 | 1995-10-31 | Colgate-Palmolive Co. | Liquid cleaning compositions |
US5843215A (en) * | 1997-04-07 | 1998-12-01 | Warmm Sciences, Llc | Insect repellent coatings |
US5935272A (en) * | 1999-02-02 | 1999-08-10 | Milliken & Company | Compositions comprising aryloxypolyoxyalkylene naphthalimide derivative colorants |
US6482455B1 (en) * | 1999-11-11 | 2002-11-19 | Inabonos S.A. | Natural source composition for the control of post-harvest pathologies and methods of application |
US20040161517A1 (en) * | 2003-02-14 | 2004-08-19 | Paul Winniczuk | Food and beverage preservative |
US7226610B2 (en) * | 2005-03-30 | 2007-06-05 | Preservation Sciences, Inc. | Compositions and methods for the treatment and prevention of disease in plants |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100092631A1 (en) * | 2007-02-16 | 2010-04-15 | Alberto Sardo | Combinations of abietic acid esters with one or mote terpenes and use thereof for coating fruit or vegetables |
US8691307B2 (en) | 2007-02-16 | 2014-04-08 | Xeda International | Combinations of abietic acid esters with one or more terpenes and use thereof for coating fruit or vegetables |
Also Published As
Publication number | Publication date |
---|---|
WO2006105342A1 (en) | 2006-10-05 |
US20070196409A1 (en) | 2007-08-23 |
US20060222674A1 (en) | 2006-10-05 |
US7226610B2 (en) | 2007-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113164885B (en) | Antimicrobial Nanoemulsions | |
Zhang et al. | Recent developments in the enhancement of some postharvest biocontrol agents with unconventional chemicals compounds | |
EP2053921B1 (en) | A new antifungal composition | |
US20080021114A1 (en) | Compositions and Methods for the Prevention and Treatment of Diseases in Plants | |
US20090018194A1 (en) | Use of antimicrobial agents derived from alliaceous plants for the prevention and control of crop diseases, post-harvest rot and as environmental disinifectant products | |
US20070087978A1 (en) | Method of Controlling Animal Pests | |
KR102473524B1 (en) | A composition containing a mixture containing at least fludioxonil and Aureobasidium pullulans strains | |
DE60205148T2 (en) | Biopesticide compositions | |
WO2019012541A1 (en) | Microbial composition and methods of use thereof | |
EP2068627A1 (en) | Agent for treating and/or preventing fire blight | |
Gómez-Gálvez et al. | Suppressive and preventive activity of chemical disinfectants against sclerotia of Verticillium dahliae in water | |
Khaleel et al. | Coating of orange fruit with nano-silver particles to minimizing harmful environmental pollution by chemical fungicide | |
CA3126109A1 (en) | A fungicidal composition comprising hibiscus leaf extract and karanj oil and uses thereof | |
Dal Bello et al. | Postharvest control of Botrytis gray mould in tomato by antagonists and biorational compounds | |
CA3053322A1 (en) | Compositions and methods to treat plant pathogens | |
Youssef et al. | Preliminary studies on fungal species associated with guava fruit drop disease and possible management | |
CN106106529A (en) | A kind of new type water rice field compound disinfectant and application thereof | |
KR20210082803A (en) | Disinfectant to the fire blight | |
Walter et al. | Timing of fungicide application for Botrytis cinerea control in blackcurrant (Ribes nigrum) | |
CN115067364B (en) | High-efficiency low-toxicity low-residual-risk bio-chemical synergistic bactericidal composition and application thereof | |
Abdel-Mageed et al. | Controlling the grey mold and white rot diseases on bean pods under storage conditions using some safely chemical compounds | |
CN116473113A (en) | Tuber crop bud inhibitor and preparation method and application thereof | |
Radwan | Mango grafting failure disease: associated fungi and possible control | |
Yousif et al. | Evaluation of salicylic acid solution on fungus Botrytis cinerea that caused strawberry gray mold | |
Shahi et al. | Assessment of broad spectrum control potential of Eucalyptus citriodora oil against post harvest spoilage of Malus pumilo L |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TRANSFER TECHNOLOGIES INTERNATIONAL CORPORATION, F Free format text: PURCHASE AGREEMENT;ASSIGNOR:SB INVESTMENT TRUST;REEL/FRAME:020817/0827 Effective date: 20080402 Owner name: HYMAN, LARRY S., FLORIDA Free format text: COURT ORDER;ASSIGNOR:PRESERVATION SCIENCES, INC.;REEL/FRAME:020817/0799 Effective date: 20080114 Owner name: SB INVESTMENT TRUST, FLORIDA Free format text: COURT ORDER;ASSIGNOR:HYMAN, LARRY S.;REEL/FRAME:020817/0811 Effective date: 20080124 |
|
AS | Assignment |
Owner name: PRESERVATION SCIENCES, INC., FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ELLINGER, EMERY;REEL/FRAME:020842/0919 Effective date: 20070405 |
|
AS | Assignment |
Owner name: PRESERVATION SCIENCES, INC., FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WINNICZUK, PAUL;REEL/FRAME:020856/0628 Effective date: 20051119 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |